Teledentistry can increase access for patients with obstructive sleep apnea, but the AADSM recently updated dental sleep medicine standards to clarify that specific steps should only be done in person.
Key milestones include FDA clearance for its pediatric device and the issuance of new insurance codes to expand market reach.
A study published in Annals of the American Thoracic Society demonstrates a promising new method for titrating oral appliances.
Other Q2 highlights included a $7.5 million equity investment, positive results from a marketing pilot, and over 45,000 patients treated with Vivos’ OSA devices.
Read More
Slide2Sleep’s nylon model, released in June 2023, offers increased strength and a slimmer profile over its acrylic predecessor.
Read More
OrthoApnea NOA was cleared by the US Food and Drug Administration in 2021 for treating obstructive sleep apnea and snoring.
Read More
Total Snooze, a new sleep treatment center in St George, Utah, has partnered with Apple a Day Dental to tackle undiagnosed sleep apnea and provide solutions.
Read More
Why manufacturers are increasingly turning to 3D-printed nylon polyamide 12 for oral appliance therapy for obstructive sleep apnea.
Read More
The American Academy of Dental Sleep Medicine has installed a new president who aims to enhance awareness and access to oral appliance therapy for sleep apnea.
Read More
Eight out of 10 newly diagnosed OSA patients choose oral appliance therapy over CPAP or doing nothing.
Read More
The 3D-printed oral appliance is indicated for the treatment of snoring and mild to moderate obstructive sleep apnea.
Read More
The milestone follows a settlement with ResMed, resolving all patent infringement litigation related to Panthera’s mandibular repositioning devices.
Read More
Sat Sharma received the AADSM Clinical Research Award for demonstrating that sleep apnea-specific hypoxic burden is a more accurate predictor of OSA-related risk and treatment efficacy than the traditional AHI.
Read More
As CPAP challenges persist, sleep specialists turn to endotyping and alternative therapies to personalize OSA care.
Read More
Research to be presented at SLEEP 2024 indicates ProSomnus’ oral appliances improve OSA treatment outcomes and patient satisfaction.
Read More
The company achieved a 28% increase in revenue, reaching $7.5 million, and maintained high on-time delivery rates.
Read More
Accepted abstracts for the 2024 AADSM Annual Meeting explore enhanced health outcomes in OSA treatment with oral appliances and reduced staining in medical-grade class VI devices.
Read More
Johns Dental Laboratories failed to alert the FDA about complaints related to the AGGA dental device, which allegedly harmed patients and is now under criminal investigation.
Read More